Results 111 to 120 of about 1,814 (132)

Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg. [PDF]

Ophthalmol Ther
Sherif MZ, Teo KYC, Lai TYY, Chan HH, Fenner BJ, Lee WK, Cheung CMG.   +6 more
europepmc   +1 more source

"Real world outcomes of intravitreal brolucizumab for persistent diabetic macular edema". [PDF]

Int J Retina Vitreous
Hansraj S, Narula R, Raval VR, Narayanan R, Tyagi M.   +4 more
europepmc   +1 more source

Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk. [PDF]

Int J Retina Vitreous
Antonietti M, Mercado C, Smiddy WE, Schwartz SG.   +3 more
europepmc   +1 more source

Association of Molar Dose and Early Retinochoroidal Blood Flow Changes After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy. [PDF]

Invest Ophthalmol Vis Sci
Kato N, Haruta M, Arai R, Nagae A, Sato K, Furushima K, Yoshida S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies

Drug Design, Development and Therapy, 2022
Georgios D Panos
exaly  

Sub-Tenon’s capsule triamcinolone acetonide injection to prevent brolucizumab-associated intraocular inflammation

Graefe's Archive for Clinical and Experimental Ophthalmology, 2022
Taiichi Hikichi
exaly  

Efficacy and safety of brolucizumab in age‐related macular degeneration: A systematic review of real‐world studies

Acta Ophthalmologica, 2023
Torben Lykke Sørensen
exaly  

Clinical Characteristics and Outcomes of Eyes with Intraocular Inflammation after Brolucizumab: Post Hoc Analysis of HAWK and HARRIER

Ophthalmology Retina, 2022
Peter Kaiser, Bahram Bodaghi
exaly  

Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study

Journal of Clinical Medicine, 2021
Viraj Vasavada, Alper Bilgic, Aditya Sudhalkar   +2 more
exaly  

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study

Journal of Clinical Medicine, 2021
Alper Bilgic, Aditya Sudhalkar, Alay Banker   +2 more
exaly